Page last updated: 2024-08-22

phenethyl isothiocyanate and Carcinoma, Ductal, Pancreatic

phenethyl isothiocyanate has been researched along with Carcinoma, Ductal, Pancreatic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aguilar, M; Chiao, PJ; Fu, J; Gocho, T; Huang, P; Ju, HQ; Wu, M; Yanaga, K; Zhuang, ZN1

Other Studies

1 other study(ies) available for phenethyl isothiocyanate and Carcinoma, Ductal, Pancreatic

ArticleYear
Mechanisms of Overcoming Intrinsic Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma through the Redox Modulation.
    Molecular cancer therapeutics, 2015, Volume: 14, Issue:3

    Topics: Adenocarcinoma; Animals; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Deoxycytidine; Drug Resistance, Neoplasm; Gemcitabine; Glutathione; Humans; Isothiocyanates; Mice; Mice, Inbred NOD; Mice, SCID; NF-E2-Related Factor 2; NF-kappa B; Oxidation-Reduction; Pancreatic Neoplasms; Reactive Oxygen Species; RNA Interference; Signal Transduction; Xenograft Model Antitumor Assays

2015